sulfamethoxazole has been researched along with Egyptian Ophthalmia in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nisbet, IT | 1 |
| Graham, DM | 1 |
| Spicer, PE | 1 |
| Tibbs, GJ | 1 |
1 trial available for sulfamethoxazole and Egyptian Ophthalmia
| Article | Year |
|---|---|
Chlorhexidine as an effective agent against Chlamydia trachomatis in vitro and in vivo.
Topics: Child, Preschool; Chlamydia trachomatis; Chlorhexidine; HeLa Cells; Humans; Placebos; Sulfamethoxazo | 1979 |